Sharps Compliance Acquires Midwest Medical Waste Expanding its Route Based Services and Footprint in Kansas
07 Febrero 2022 - 7:00AM
Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”),
a leading full-service national provider of comprehensive waste
management solutions including medical, pharmaceutical and
hazardous, today announced the acquisition of Midwest Medical
Waste, Inc., a full-service, route-based provider of medical and
hazardous waste solutions serving over 600 customer locations
across Kansas. The purchase price was $4.35 million and consisted
of 75% in cash and 25% in Sharps Compliance stock.
David P. Tusa, President and Chief Executive
Officer of Sharps, stated, “Our acquisition of Midwest Medical
Waste of Kansas aligns well with our strategy to augment our
organic growth initiatives with complementary acquisitions that
increase our route density and extend our reach in the marketplace.
Midwest Medical Waste has established a strong reputation as a
customer focused medical waste management provider in Kansas. We
believe this acquisition will enhance our route-based coverage and
capabilities in Kansas and further our overall leadership position
as a comprehensive provider of medical waste management
solutions.”
Tusa added, “We have a vibrant pipeline of
acquisition opportunities in various stages that we are evaluating.
We are pleased to kick off calendar 2022 with the addition of
Midwest Medical Waste of Kansas.”
About Sharps Compliance
Corp.
Headquartered in Houston, Texas, Sharps
Compliance (NASDAQ: SMED) is a leading business-to-business
services provider to the healthcare, long-term care and retail
pharmacy markets. Sharps Compliance offers comprehensive solutions
for the management of regulated medical waste, hazardous waste and
unused medications. For more information, visit:
www.sharpsinc.com.
Forward-Looking Statements
The information made available in this news
release contains certain forward-looking statements relating to the
Company that are based on the beliefs of the Company’s management
as well as assumptions made by and information currently available
to the Company’s management. When used in this document, the words
"may," “position,” "plan," “potential,” “designed,” “continue,”
"anticipate," "believe," "expect," "estimate," “project,” and
“intend” and words or phrases of similar import, as they relate to
the Company or its subsidiaries or Company management, are intended
to identify forward-looking statements. Such statements reflect the
known and unknown risks, uncertainties and assumptions
related to certain factors including, without limitation,
competitive factors, general economic conditions, customer
relations, relationships with vendors, governmental regulation and
supervision, seasonality, distribution networks, product
introductions and acceptance, technological change, changes in
industry practices, onetime events and other factors described
herein including the impact of the coronavirus COVID-19
(“COVID-19”) pandemic on our operations and financial results.
Based upon changing conditions, should any one or more of these
risks or uncertainties materialize, or should any underlying
assumptions prove incorrect, actual results may vary materially
from those described herein as anticipated, believed, estimated,
expected or intended. Consequently, no forward-looking statements
can be guaranteed. When considering these forward-looking
statements, you should keep in mind the risk factors and other
cautionary statements in the Company’s Quarterly Reports on Form
10-Q, our Annual Report on Form 10-K, and our other filings with
the Securities and Exchange Commission. Actual results may vary
materially. You are cautioned not to place undue reliance on any
forward-looking statements. You should also understand that it is
not possible to predict or identify all such factors and as such
should not consider the preceding list or the risk factors to be a
complete list of all potential risks and uncertainties. The Company
does not intend to update these forward-looking statements.
For more information
contact:
Diana P. DiazSharps Compliance
Corp.Executive Vice President and Chief Financial OfficerPhone:
(713) 660-3547Email: ddiaz@sharpsinc.com |
John Nesbett/Jennifer BelodeauIMS Investor RelationsPhone: (203)
972-9200Email: jnesbett@institutionalms.com |
Sharps Compliance (NASDAQ:SMED)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Sharps Compliance (NASDAQ:SMED)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024